A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

NCT04083976 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Erdafitinib

Sponsor

Janssen Research & Development, LLC